AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 ...
(MENAFN- PR Newswire) MariTide Demonstrated up to ~20% Average weight loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight MariTide is the First Obesity treatment With Monthly or Less Frequent Dosing to Demonstrate …